Wegovy for Children: Safety & Future Availability

The drug Wegovy, which contains the active substance semaglutide, is used to treat obesity in adults. However, it is currently not approved for use in children. Clinical studies and trials to assess the safety and effectiveness of semaglutide in children are ongoing, and the results will determine whether the drug may be approved for use in pediatric populations in the future.

It is important to consult a healthcare professional for accurate and up-to-date information regarding the use of semaglutide for obesity in children, as the approval status and treatment guidelines may change based on ongoing research. Self-treating or administering unauthorized medications to children can be risky and should be avoided.